Mayo Clinic
Drug improves survival of colorectal cancer patients, trial results show
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented ...
Cancer
Jan 18, 2012 |
not rated yet |
0
Studies identify risk factors in rising trend of liver cancer
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Pr ...
Cancer
Jan 03, 2012 |
4 / 5 (1) |
0
'Rare' brain disorder may be more common than thought: study
A global team of neuroscientists, led by researchers at Mayo Clinic in Florida, have found the gene responsible for a brain disorder that may be much more common than once believed. In the Dec. 25 online issue of Nature Ge ...
Genetics
Dec 25, 2011 |
4.7 / 5 (7) |
0
|
Obesity linked to higher 5-year death rate after esophageal cancer surgery
Obesity doubles the risk of cancer recurrence and cancer-related death in patients with esophageal cancer who have been treated with surgery, researchers at Mayo Clinic found. Their 778-patient study, which appeared in the ...
Surgery
Dec 20, 2011 |
not rated yet |
0
Angioplasties performed at centers without on-site surgery services are safe, study finds
Contrary to current guidelines, Mayo Clinic researchers have found that angioplasties performed at centers without on-site cardiac surgery capabilities pose no increased risk for patient death or emergency bypass surgery. ...
Surgery
Dec 13, 2011 |
not rated yet |
0
Ruxolinitib better at reducing myelofibrosis symptoms, study shows
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills ...
Cancer
Dec 12, 2011 |
not rated yet |
0
How patients will respond to immunomodulator therapy for multiple myeloma
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of ...
Cancer
Dec 11, 2011 |
5 / 5 (1) |
0
Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer
Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient's outcome after treatment for HER2-Positive Breast Cancer ...
Cancer
Dec 09, 2011 |
not rated yet |
0
Obese patients with HER2-positive breast cancer may have worse outcomes
Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, Mayo Clinic researchers found in a study presented today at the 2011 CTRC-AACR San Antonio Breast Ca ...
Cancer
Dec 08, 2011 |
not rated yet |
0
Multiple sclerosis often starts in brain's outer layers: study
Multiple sclerosis (MS) may progress from the outermost layers of the brain to its deep parts, and isn't always an "inside-out" process as previously thought, reported a new collaborative study from researchers at the Mayo ...
Medical research
Dec 07, 2011 |
5 / 5 (1) |
0
|
Researchers find drug duo kills chemotherapy-resistant ovarian cancer cells
The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida. ...
Cancer
Dec 07, 2011 |
not rated yet |
0
Mayo Clinic makes kidney and pancreas transplant available to HIV-infected patients
Mayo Clinic in Florida is now offering kidney and pancreas transplants to HIV positive patients with advanced kidney disease and diabetes. Evidence is now solid that HIV-positive patients have the same favorable outcome in ...
Other
Dec 06, 2011 |
not rated yet |
0
Rresearch improves diagnosis and potential treatment of neuromyelitis optica
Mayo Clinic researchers have identified critical steps leading to myelin destruction in neuromyelitis optica (NMO), a debilitating neurological disease that is commonly misdiagnosed as multiple sclerosis (MS). The findings ...
Medical research
Dec 02, 2011 |
5 / 5 (1) |
0
Study confirms smoke-free workplaces reduce heart attacks
Mayo Clinic researchers have amassed additional evidence that secondhand smoke kills and smoke-free workplace laws save lives. The study will be presented to the American Heart Association's Scientific Sessions on Monday ...
Health
Nov 14, 2011 |
5 / 5 (2) |
0
|
Study finds CT scans can help detect gout cases traditional tests miss
X-ray images known as CT scans can help confirm gout in patients who are suspected of having the painful condition but receive negative results from traditional tests, a Mayo Clinic study has found. The type of CT scan analyzed, ...
Cancer
Nov 06, 2011 |
5 / 5 (1) |
0
